← Back
Data updated: Mar 29, 2026
SHUANGCHENG
Cardiovascular
Generics
SHUANGCHENG is a generic drug manufacturer focused on Cardiovascular.
2019
Since
5
Drugs
-
Trials
31
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
BORTEZOMIB 2026-01-06
BORTEZOMIB 2025-12-17
OCTREOTIDE ACETATE 2025-12-12
PACLITAXEL 2025-08-19
PACLITAXEL 2025-07-10
Labeling
EPTIFIBATIDE 2025-06-13
Labeling
BORTEZOMIB 2025-06-02
PACLITAXEL 2025-05-15
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (3)
Discontinued (1)
Company Info
- First Approval
- 2019-10-23
- Latest
- 2025-12-17
- Applications
- 5